Rhumbline Advisers Zimmer Biomet Holdings, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 412,051 shares of ZBH stock, worth $44 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

412,051

Previous 415,779 0.9%

Holding current value

$44 Million

Previous $45.1 Million 1.44%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$104.47 - $116.17 $389,464 - $433,081	-3,728 Reduced 0.9%	412,051 $44.5 Million
Q2 2024 Aug 01, 2024	SELL	$106.25 - $130.01 $1.63 Million - $2 Million	-15,363 Reduced 3.56%	415,779 $45.1 Million
Q1 2024 May 09, 2024	BUY	$119.98 - $132.61 $1 Million - $1.11 Million	8,355 Added 1.98%	431,142 $56.9 Million
Q4 2023 Feb 08, 2024	SELL	$102.72 - $121.7 $328,087 - $388,709	-3,194 Reduced 0.75%	422,787 $51.5 Million
Q3 2023 Nov 09, 2023	SELL	$110.76 - $143.18 $982,551 - $1.27 Million	-8,871 Reduced 2.04%	425,981 $47.8 Million
Q2 2023 Aug 08, 2023	SELL	$126.43 - $145.6 $160,566 - $184,912	-1,270 Reduced 0.29%	434,852 $63.3 Million
Q1 2023 May 11, 2023	BUY	$121.91 - $130.94 $1.31 Million - $1.4 Million	10,707 Added 2.52%	436,122 $56.3 Million
Q4 2022 Feb 14, 2023	BUY	$104.7 - $128.4 $1.53 Million - $1.88 Million	14,642 Added 3.56%	425,415 $54.2 Million
Q3 2022 Nov 10, 2022	BUY	$101.65 - $119.27 $1.66 Million - $1.95 Million	16,358 Added 4.15%	410,773 $42.9 Million
Q2 2022 Aug 11, 2022	BUY	$102.23 - $133.85 $1.98 Million - $2.6 Million	19,413 Added 5.18%	394,415 $41.4 Million
Q1 2022 May 12, 2022	BUY	$108.42 - $129.58 $1.18 Million - $1.41 Million	10,859 Added 2.98%	375,002 $48 Million
Q4 2021 Feb 10, 2022	BUY	$115.43 - $146.63 $834,443 - $1.06 Million	7,229 Added 2.03%	364,143 $46.3 Million
Q3 2021 Nov 12, 2021	SELL	$136.35 - $158.76 $371,008 - $431,985	-2,721 Reduced 0.76%	356,914 $52.2 Million
Q2 2021 Aug 05, 2021	SELL	$152.95 - $173.41 $576,774 - $653,929	-3,771 Reduced 1.04%	359,635 $57.8 Million
Q1 2021 May 06, 2021	SELL	$148.16 - $159.71 $3.18 Million - $3.43 Million	-21,487 Reduced 5.58%	363,406 $58.2 Million
Q4 2020 Feb 10, 2021	BUY	$128.25 - $151.41 $867,996 - $1.02 Million	6,768 Added 1.79%	384,893 $59.3 Million
Q3 2020 Nov 12, 2020	SELL	$113.59 - $141.68 $200,031 - $249,498	-1,761 Reduced 0.46%	378,125 $51.5 Million
Q2 2020 Aug 13, 2020	SELL	$87.02 - $133.4 $666,399 - $1.02 Million	-7,658 Reduced 1.98%	379,886 $45.3 Million
Q1 2020 May 06, 2020	BUY	$78.28 - $155.73 $2.21 Million - $4.4 Million	28,277 Added 7.87%	387,544 $39.2 Million
Q4 2019 Feb 05, 2020	BUY	$127.4 - $146.83 $1.46 Million - $1.68 Million	11,469 Added 3.3%	359,267 $53.8 Million
Q3 2019 Oct 23, 2019	BUY	$113.33 - $138.46 $764,524 - $934,051	6,746 Added 1.98%	347,798 $47.7 Million
Q2 2019 Aug 14, 2019	BUY	$108.87 - $125.09 $245,392 - $281,952	2,254 Added 0.67%	341,052 $40.2 Million
Q1 2019 May 01, 2019	SELL	$97.5 - $125.79 $3.04 Million - $3.92 Million	-31,200 Reduced 8.43%	338,798 $43.3 Million
Q4 2018 Jan 31, 2019	BUY	$94.4 - $126.76 $103,934 - $139,562	1,101 Added 0.3%	369,998 $38.4 Million
Q3 2018 Nov 07, 2018	SELL	$108.41 - $127.64 $976,990 - $1.15 Million	-9,012 Reduced 2.38%	368,897 $48.5 Million
Q2 2018 Aug 06, 2018	SELL	$102.12 - $114.04 $503,962 - $562,787	-4,935 Reduced 1.29%	377,909 $42.1 Million
Q1 2018 May 02, 2018	SELL	$104.31 - $124.46 $167,521 - $199,882	-1,606 Reduced 0.42%	382,844 $41.7 Million
Q4 2017 Feb 09, 2018	BUY	$105.55 - $120.83 $888,308 - $1.02 Million	8,416 Added 2.24%	384,450 $46.4 Million
Q3 2017 Nov 06, 2017	BUY	$106.92 - $117.79 $40.2 Million - $44.3 Million	376,034	376,034 $44 Million

Others Institutions Holding ZBH

# of Institutions

1,079

Shares Held

178M

Call Options Held

301K

Put Options Held

View Full List

About ZIMMER BIOMET HOLDINGS, INC.

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $22.4B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

More about ZBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Zimmer Biomet Holdings, Inc. Transaction History